Volume 234, issue 2, January 2017
15 articles in this issue
-
-
-
Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion
Authors (first, second and last of 4)
-
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Authors (first, second and last of 8)
-
MK-801-induced impairments on the trial-unique, delayed nonmatching-to-location task in rats: effects of acute sodium nitroprusside
Authors (first, second and last of 6)
-
Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents
Authors (first, second and last of 6)
-
Haloperidol 2 mg impairs inhibition but not visuospatial attention
Authors (first, second and last of 8)
-
Naturalistic assessment of demand for cigarettes, snus, and nicotine gum
Authors (first, second and last of 5)
-
-
BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology
Authors (first, second and last of 11)
-
Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice
Authors (first, second and last of 6)
-
Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline
Authors (first, second and last of 5)
-
Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults
Authors (first, second and last of 7)
-
Nicotinic cholinergic system alterations and nitrous oxide exposure in a mouse model: a hypothesis for the pathobiology of autism spectrum disorder
Authors (first, second and last of 4)
-
